USA Network has expanded its scripted slate with a straight-to-series order for “Diplomatic Immunity,” an hour-long medical drama set in Rome. The series comes from Matt Corman and Chris Ord, the writing duo best known for creating the long-running spy drama “Covert Affairs,” which aired for five seasons on the network.
The show centers on a young American doctor who is suddenly thrust into a high-pressure medical environment abroad, where diplomatic tensions and personal stakes collide with the daily demands of saving lives. The project is produced by Fox Entertainment Studios, marking another collaboration between the studio and the cable network.
“Diplomatic Immunity” joins a growing roster of original programming at USA Network, which has been steadily rebuilding its scripted identity. The new drama will sit alongside “The Rainmaker,” an adaptation of the John Grisham novel, and “Anna Pigeon,” a recently launched series based on the Nevada Barr book franchise. The three shows represent the network’s renewed push into premium, character-driven storytelling after years of focusing on unscripted and acquired content.
For Corman and Ord, the project marks a return to USA Network, where they established themselves as reliable creators of serialized television. Their previous collaboration, “Covert Affairs,” became one of the network’s signature hits during its run, blending international intrigue with a strong central performance. The pair have since worked on a range of projects across broadcast and streaming, but “Diplomatic Immunity” brings them back to familiar ground with a fresh genre twist.
The medical drama genre has seen a resurgence in recent years, with shows like “The Pitt” and “Doc” drawing strong audiences and critical attention. USA Network’s decision to enter that space with a Rome-set premise suggests an effort to differentiate its offering through location and atmosphere, rather than competing directly with hospital procedurals set in American cities. The diplomatic angle also allows for storylines that intersect with geopolitics, espionage, and cultural clash, giving the writers room to explore themes beyond standard medical cases.
No casting announcements have been made yet, and a premiere date has not been set. The series is in early development, with production expected to begin once the creative team finalizes the pilot script and locks in a showrunner. Fox Entertainment Studios will serve as the production entity, with Corman and Ord attached as writers and executive producers.
The order is part of a broader strategy at USA Network to reestablish itself as a destination for original drama. The network, once home to hits like “Mr. Robot,” “Suits,” and “Royal Pains,” has spent the past several years retooling its approach under new leadership. The addition of “Diplomatic Immunity” signals confidence in the scripted market and in the creative team behind the project.
As the series moves forward, industry observers will be watching to see how the network positions the show alongside its other upcoming dramas. With three original series now in various stages of production, USA Network appears committed to a slate that balances established IP with fresh concepts. “Diplomatic Immunity” fits that model, offering a familiar genre with a distinctive setting and a proven creative team at the helm.